Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
58 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-61 |
Cash Flow (TTM) (Millions $) |
1 |
Capital Exp. (TTM) (Millions $) |
0 |
Tricida Inc
Tricida Inc. is a pharmaceutical company that focuses on the development and commercialization of therapies for patients with chronic kidney disease (CKD). The company's main goal is to improve the lives of CKD patients by developing innovative treatments that target the underlying causes of the disease. Tricida's pipeline includes potential therapies for metabolic acidosis, a common complication of CKD that can lead to various health issues. Additionally, the company is committed to conducting rigorous clinical research and collaborating with healthcare professionals to advance CKD care.
Company Address: 7000 Shoreline Court South San Francisco 94080 CA
Company Phone Number: 429-7800 Stock Exchange / Ticker: NASDAQ TCDA
|